![Phase 1 clinical study reveals how stem cells alleviate COPD inflammation in humans - World Stem Cell Summit Phase 1 clinical study reveals how stem cells alleviate COPD inflammation in humans - World Stem Cell Summit](https://www.regmedfoundation.org/wp-content/uploads/2021/08/2021-08-18_Phase-1-clinical-study-reveals-how-stem-cells-alleviate-COPD-inflammation-in-humans.jpg)
Phase 1 clinical study reveals how stem cells alleviate COPD inflammation in humans - World Stem Cell Summit
![Progress in the mechanism and targeted drug therapy for COPD | Signal Transduction and Targeted Therapy Progress in the mechanism and targeted drug therapy for COPD | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00345-x/MediaObjects/41392_2020_345_Fig1_HTML.png)
Progress in the mechanism and targeted drug therapy for COPD | Signal Transduction and Targeted Therapy
![The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision | European Respiratory Society The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision | European Respiratory Society](https://erj.ersjournals.com/content/erj/56/1/2000627/F2.large.jpg)
The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision | European Respiratory Society
![The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision | European Respiratory Society The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision | European Respiratory Society](https://erj.ersjournals.com/content/erj/56/1/2000627/F1.large.jpg)
The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision | European Respiratory Society
Full article: A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease
![Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial | Respiratory Research | Full Text Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12931-020-01431-y/MediaObjects/12931_2020_1431_Figa_HTML.png)
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial | Respiratory Research | Full Text
![R01713_community-based-patients-with-COPD -who-meet-eligibility-criteria-for-published-clinical-trials -of-long-acting-bronchodilator-therapy-for-COPD-Pilot-phase_REG2014 - OPRI R01713_community-based-patients-with-COPD -who-meet-eligibility-criteria-for-published-clinical-trials -of-long-acting-bronchodilator-therapy-for-COPD-Pilot-phase_REG2014 - OPRI](https://opri.sg/wp-content/uploads/2014/06/R01713_community-based-patients-with-COPD-who-meet-eligibility-criteria-for-published-clinical-trials-of-long-acting-bronchodilator-therapy-for-COPD-Pilot-phase_REG2014.jpg)
R01713_community-based-patients-with-COPD -who-meet-eligibility-criteria-for-published-clinical-trials -of-long-acting-bronchodilator-therapy-for-COPD-Pilot-phase_REG2014 - OPRI
![Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials | SpringerLink Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-020-01411-0/MediaObjects/12325_2020_1411_Figa_HTML.png)
Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials | SpringerLink
![Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD > Journal of the COPD Foundation Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD > Journal of the COPD Foundation](http://journal.copdfoundation.org/Portals/0/JCOPDF/images/Volume3-Issue2/JCOPDF-2015-0152-Figure1.jpg)
Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD > Journal of the COPD Foundation
![Summary of ongoing clinical trials targeting IL-33 pathway in COPD and... | Download Scientific Diagram Summary of ongoing clinical trials targeting IL-33 pathway in COPD and... | Download Scientific Diagram](https://www.researchgate.net/profile/Agata-Gabryelska/publication/332441545/figure/tbl1/AS:748246003617793@1555407157241/Summary-of-ongoing-clinical-trials-targeting-IL-33-pathway-in-COPD-and-asthma.png)